News & Updates

Show Multimedia Only

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

The combination of chemotherapy and anti-EGFR/BRAF therapy provides optimal survival benefits to patients with advanced BRAF-mutated colorectal cancer (CRC), according to a study.

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

12 hours ago

Liver transplant tied to better survival than systemic therapy only in nonmetastatic HCC

07 Dec 2025

In patients with nonmetastatic hepatocellular carcinoma (HCC), treatment with upfront liver transplant or liver transplant with bridge systemic therapy results in significantly better improvements in overall survival (OS) compared with systemic therapy only, according to a study.

Liver transplant tied to better survival than systemic therapy only in nonmetastatic HCC

07 Dec 2025

Antioxidant-rich food lowers risk of gastric cancer

06 Dec 2025 by

Eating foods that are rich in antioxidants appears to reduce the risk of gastric cancer (GC), suggests a recent study.

Antioxidant-rich food lowers risk of gastric cancer

06 Dec 2025

Does RAIT increase the risk of second primary malignancies in patients with PTC?

05 Dec 2025

In patients with papillary thyroid cancer (PTC), radioactive iodine therapy (RAIT) does not appear to increase the risk of a second primary malignancy (SPM), reports a study. On the other hand, age and personal or family history of cancer are predictive of SPM in this population.

Does RAIT increase the risk of second primary malignancies in patients with PTC?

05 Dec 2025

Arsenic not a risk factor for prostate cancer

04 Dec 2025

Arsenic exposure in drinking water, even at high levels, does not appear to contribute to an increased risk of prostate cancer, according to a case–control study.

Arsenic not a risk factor for prostate cancer

04 Dec 2025

Ipatasertib shows promising activity against AKT1E17K-mutant tumours

04 Dec 2025

Treatment with the pan-AKT inhibitor ipatasertib appears to induce response in patients with tumours harbouring AKT1E17K mutations, according to a study.

Ipatasertib shows promising activity against AKT1E17K-mutant tumours

04 Dec 2025

$Pancreatic cancer: What’s the optimal Tx sequence for hypofractionated proton beam therapy with simultaneous integrated boost$

Pancreatic cancer: What’s the optimal Tx sequence for hypofractionated proton beam therapy with simultaneous integrated boost?

04 Dec 2025 by

Hypofractionated proton beam therapy with simultaneous integrated boost technique (SIB-PBT) can be used as a safe and effective local treatment for locally advanced pancreatic cancer (LAPC), particularly in patients with stable disease (SD) following induction chemotherapy, according to findings from the largest cohort to date presented at PTCOG-AO 2025.

Pancreatic cancer: What’s the optimal Tx sequence for hypofractionated proton beam therapy with simultaneous integrated boost?

04 Dec 2025

Original New Drug Application Approvals by US FDA (16-31 October 2025)

02 Dec 2025

New drug applications approved by US FDA as of 16-31 October 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (16-31 October 2025)

02 Dec 2025

Dietary fibre intake may lessen bowel-related symptoms in CRC survivors

30 Nov 2025

For survivors of colorectal cancer (CRC), consuming more fibre in their daily diet helps reduce bowel-related symptoms, according to a study.

Dietary fibre intake may lessen bowel-related symptoms in CRC survivors

30 Nov 2025

ICI-induced endocrinopathies: Patient education, regular monitoring, and early appropriate management important

28 Nov 2025 by

Regular monitoring and recognizing tell-tale signs upon first presentation are important in managing endocrine immune-related adverse events (irAEs) induced by immune checkpoint inhibitors (ICIs), for optimized cancer treatment outcomes, stressed Dr David Lui from the University of Hong Kong, at the 8^th Endocrinology, Diabetes & Metabolism Hong Kong Annual Meeting (EDM HK 2025).

ICI-induced endocrinopathies: Patient education, regular monitoring, and early appropriate management important

28 Nov 2025

News & Updates

Showing Oncology articles

Showing

Specialty:

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Chemo plus targeted therapy extends survival in advanced BRAF-mutated CRC

Liver transplant tied to better survival than systemic therapy only in nonmetastatic HCC

Liver transplant tied to better survival than systemic therapy only in nonmetastatic HCC

Antioxidant-rich food lowers risk of gastric cancer

Antioxidant-rich food lowers risk of gastric cancer

Does RAIT increase the risk of second primary malignancies in patients with PTC?

Does RAIT increase the risk of second primary malignancies in patients with PTC?

Arsenic not a risk factor for prostate cancer

Arsenic not a risk factor for prostate cancer

Ipatasertib shows promising activity against AKT1E17K-mutant tumours

Ipatasertib shows promising activity against AKT1E17K-mutant tumours

Pancreatic cancer: What’s the optimal Tx sequence for hypofractionated proton beam therapy with simultaneous integrated boost?

Pancreatic cancer: What’s the optimal Tx sequence for hypofractionated proton beam therapy with simultaneous integrated boost?

Original New Drug Application Approvals by US FDA (16-31 October 2025)

Original New Drug Application Approvals by US FDA (16-31 October 2025)

Dietary fibre intake may lessen bowel-related symptoms in CRC survivors

Dietary fibre intake may lessen bowel-related symptoms in CRC survivors

ICI-induced endocrinopathies: Patient education, regular monitoring, and early appropriate management important

ICI-induced endocrinopathies: Patient education, regular monitoring, and early appropriate management important